Allay Therapeutics (singapore Subsidiary) is VC-Backed and has raised funding across Series D and Series C2 rounds. It is backed by Allay Therapeutics, Inc..
Alternatives.pe tracks Allay Therapeutics (singapore Subsidiary)'s funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Browse all uploaded documents here
Extracted Financial Statement 2024
Extracted Financial Statement
ViewExtracted Financial Statement 2023
Extracted Financial Statement
ViewExplore the latest updates and insights
Allay Therapeutics, a clinical-stage biotechnology company announced the completion of a USD 57.5M ... see summary
Evonik has invested in the biopharmaceutical company Allay Therapeutics.
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic ... see summary
Allay Therapeutics completed a USD 25M Series B financing led by NEA, with additional participation ... see summary
Key members of the management team